These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Patients with macroprolactinaemia: clinical and radiological features. Donadio F; Barbieri A; Angioni R; Mantovani G; Beck-Peccoz P; Spada A; Lania AG Eur J Clin Invest; 2007 Jul; 37(7):552-7. PubMed ID: 17576206 [TBL] [Abstract][Full Text] [Related]
4. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers. Hattori N; Ishihara T; Saiki Y Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017 [TBL] [Abstract][Full Text] [Related]
5. Clinical and radiological features of patients with macroprolactinaemia. Strachan MW; Teoh WL; Don-Wauchope AC; Seth J; Stoddart M; Beckett GJ Clin Endocrinol (Oxf); 2003 Sep; 59(3):339-46. PubMed ID: 12919157 [TBL] [Abstract][Full Text] [Related]
6. Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas. Lewandowski KC; Gasior-Perczak D; Kowalska A; Lewinski A Gynecol Endocrinol; 2014 May; 30(5):385-7. PubMed ID: 24533748 [TBL] [Abstract][Full Text] [Related]
7. [Macroprolactinaemia]. Kostrzak A; Meczekalski B Pol Merkur Lekarski; 2010 Jul; 29(169):47-9. PubMed ID: 20712249 [TBL] [Abstract][Full Text] [Related]
8. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Olukoga AO; Kane JW Clin Endocrinol (Oxf); 1999 Jul; 51(1):119-26. PubMed ID: 10468974 [TBL] [Abstract][Full Text] [Related]
9. Macroprolactin-a cause of pseudohyperprolactinaemia. Yuen YP; Lai JP; Au KM; Chan AY; Mak TW Hong Kong Med J; 2003 Apr; 9(2):119-21. PubMed ID: 12668823 [TBL] [Abstract][Full Text] [Related]
11. Macroprolactin screening in 464 patients with hyperprolactinaemia. Lim MH; Ho CKM Malays J Pathol; 2022 Aug; 44(2):261-267. PubMed ID: 36043589 [TBL] [Abstract][Full Text] [Related]
12. The TSH response to domperidone reflects the biological activity of prolactin in macroprolactinaemia and hyperprolactinaemia. Pinto LP; Hanna FW; Evans LM; Davies JS; John R; Scanlon MF Clin Endocrinol (Oxf); 2003 Nov; 59(5):580-4. PubMed ID: 14616880 [TBL] [Abstract][Full Text] [Related]
13. Should macroprolactin be measured in all hyperprolactinaemic sera? McKenna TJ Clin Endocrinol (Oxf); 2009 Oct; 71(4):466-9. PubMed ID: 19320649 [TBL] [Abstract][Full Text] [Related]
14. Hyperprolactinaemia does not always mean 'hyperprolactinaemia'! Gezer A; Atasü T; Hekim C; Stenman UH; Hekim N Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):206-8. PubMed ID: 15653204 [TBL] [Abstract][Full Text] [Related]
15. Macroprolactinaemia, the major unknown in the differential diagnosis of hyperprolactinaemia. Cattaneo F; Kappeler D; Müller B Swiss Med Wkly; 2001 Mar; 131(9-10):122-6. PubMed ID: 11416967 [TBL] [Abstract][Full Text] [Related]
16. Interference by macroprolactin in assays for prolactin: will the Fahie-Wilson MN; Cobbaert CM; Horvath AR; Smith TP Clin Chem Lab Med; 2022 Aug; 60(9):1350-1355. PubMed ID: 35704648 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of hyperprolactinaemia with the use of the intervals for prolactin after macroforms separation. Beda-Maluga K; Pisarek H; Komorowski J; Swietoslawski J; Fuss-Chmielewska J; Winczyk K J Physiol Pharmacol; 2014 Jun; 65(3):359-64. PubMed ID: 24930507 [TBL] [Abstract][Full Text] [Related]